Works by Kaku, Kohei
Results: 241
Ice Cube Tray-Shaped Insulin Lipoatrophy Throughout the Abdomen in a Subject With Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- Letter
The Impact of Hand Strength on HbA1c, Body Mass Index and Body Composition by Group According to Sedentary Behaviour: Cross-Sectional Study in Japanese Patients with Type 2 Diabetes Mellitus.
- Published in:
- Malaysian Journal of Medical Sciences, 2024, v. 31, n. 3, p. 185, doi. 10.21315/mjms2024.31.3.14
- By:
- Publication type:
- Article
Insulin administration to an abdominal insulin ball that triggered the onset of diabetic ketoacidosis accompanied by Hamman's syndrome in a patient with type 1 diabetes mellitus.
- Published in:
- Kawasaki Medical Journal, 2024, v. 50, p. 69, doi. 10.11482/KMJ-E202450069
- By:
- Publication type:
- Article
A case of Sheehan syndrome with early postpartum panhypopituitarism and long-term partial improvement of endocrine function.
- Published in:
- Kawasaki Medical Journal, 2024, v. 50, p. 55, doi. 10.11482/KMJ-E202450055
- By:
- Publication type:
- Article
Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-84488-9
- By:
- Publication type:
- Article
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 9, p. 1239, doi. 10.1111/jdi.14247
- By:
- Publication type:
- Article
The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 7, p. 892, doi. 10.1111/jdi.14200
- By:
- Publication type:
- Article
Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 11, p. 1246, doi. 10.1111/jdi.14070
- By:
- Publication type:
- Article
Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo‐controlled trials.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 9, p. 1101, doi. 10.1111/jdi.14035
- By:
- Publication type:
- Article
A pitfall in hemoglobin A1c measurement with high performance liquid chromatography method in the diagnosis of onset of fulminant type 1 diabetes mellitus.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Serious diabetic ketoacidosis induced by insulin allergy and anti‐insulin antibody in an individual with type 2 diabetes mellitus.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 8, p. 1300, doi. 10.1111/jdi.13831
- By:
- Publication type:
- Article
Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 7, p. 1161, doi. 10.1111/jdi.13773
- By:
- Publication type:
- Article
Association between Grit Scales and adherence to regular hospital visits among Japanese patients with type 2 diabetes: Prospective observational study.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 12, p. 2259, doi. 10.1111/jdi.13599
- By:
- Publication type:
- Article
Dipeptidyl peptidase‐4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 10, p. 1805, doi. 10.1111/jdi.13543
- By:
- Publication type:
- Article
Effects of sedentary behavior and daily walking steps on body mass index and body composition: Prospective observational study using outpatient clinical data of Japanese patients with type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 9, p. 1732, doi. 10.1111/jdi.13527
- By:
- Publication type:
- Article
Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 9, p. 1610, doi. 10.1111/jdi.13525
- By:
- Publication type:
- Article
Pyogenic psoas abscess on the dorsal side, and bacterial meningitis and spinal epidural abscess on the ventral side, both of which were induced by spontaneous discitis in a patient with diabetes mellitus: A case report.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 7, p. 1301, doi. 10.1111/jdi.13461
- By:
- Publication type:
- Article
New prospects for incretin‐related drugs in the treatment of type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 7, p. 1141, doi. 10.1111/jdi.13460
- By:
- Publication type:
- Article
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real‐world clinical practice: Results of a 36‐month post‐marketing surveillance study (J‐STEP/LT).
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 2, p. 184, doi. 10.1111/jdi.13333
- By:
- Publication type:
- Article
Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control study.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 6, p. 1612, doi. 10.1111/jdi.13279
- By:
- Publication type:
- Article
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24‐month interim analysis of a long‐term post‐marketing study (J‐STEP/LT).
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 4, p. 906, doi. 10.1111/jdi.13233
- By:
- Publication type:
- Article
Impact of physical activity and sedentary time on glycated hemoglobin levels and body composition: Cross‐sectional study using outpatient clinical data of Japanese patients with type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 3, p. 633, doi. 10.1111/jdi.13185
- By:
- Publication type:
- Article
Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open‐label extension of a phase III study.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 3, p. 662, doi. 10.1111/jdi.13181
- By:
- Publication type:
- Article
New concept of the glucagon‐like peptide‐1 signaling pathway on pancreatic insulin secretion.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 2, p. 265, doi. 10.1111/jdi.13136
- By:
- Publication type:
- Article
Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end‐stage renal disease: Results from a randomized, phase 3 study.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 2, p. 373, doi. 10.1111/jdi.13126
- By:
- Publication type:
- Article
Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A subanalysis of a post‐marketing study (J‐STEP/EL Study).
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 2, p. 405, doi. 10.1111/jdi.13125
- By:
- Publication type:
- Article
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world practice: Results of 12‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT).
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 1, p. 132, doi. 10.1111/jdi.13097
- By:
- Publication type:
- Article
Long‐term safety and efficacy of the sodium–glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week open‐label, multicenter, post‐marketing clinical study
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 6, p. 1518, doi. 10.1111/jdi.13066
- By:
- Publication type:
- Article
Safety and efficacy of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world clinical practice: Results of 3‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT).
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 5, p. 1272, doi. 10.1111/jdi.13017
- By:
- Publication type:
- Article
Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 2, p. 290, doi. 10.1111/jdi.12909
- By:
- Publication type:
- Article
Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase‐4 inhibitor vildagliptin.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 1, p. 182, doi. 10.1111/jdi.12847
- By:
- Publication type:
- Article
Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 1, p. 104, doi. 10.1111/jdi.12832
- By:
- Publication type:
- Article
Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 6, p. 1261, doi. 10.1111/jdi.12860
- By:
- Publication type:
- Article
Onset of type 1 diabetes mellitus and heparin‐induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 6, p. 1381, doi. 10.1111/jdi.12811
- By:
- Publication type:
- Article
Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 6, p. 1378, doi. 10.1111/jdi.12796
- By:
- Publication type:
- Article
Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 5, p. 1119, doi. 10.1111/jdi.12813
- By:
- Publication type:
- Article
Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of a phase 3 randomized clinical trial.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 840, doi. 10.1111/jdi.12793
- By:
- Publication type:
- Article
Switching from low‐dose thiazide diuretics to sodium–glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 875, doi. 10.1111/jdi.12774
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitor, tofogliflozin, shows better improvements of blood glucose and insulin secretion in patients with high insulin levels at baseline.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 862, doi. 10.1111/jdi.12761
- By:
- Publication type:
- Article
Safety and efficacy of the combination of the glucagon‐like peptide‐1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post‐hoc analysis of a randomized, 52‐week, open‐label, parallel‐group trial
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 831, doi. 10.1111/jdi.12759
- By:
- Publication type:
- Article
Efficacy and safety of once‐weekly oral trelagliptin switched from once‐daily dipeptidyl peptidase‐4 inhibitor in patients with type 2 diabetes mellitus: An open‐label, phase 3 exploratory study.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 2, p. 354, doi. 10.1111/jdi.12730
- By:
- Publication type:
- Article
Aggravation of type 2 diabetes mellitus triggered by acute exacerbation of chronic thyroiditis (Hashimoto's disease).
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 1, p. 226, doi. 10.1111/jdi.12648
- By:
- Publication type:
- Article
Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post-marketing study (J- STEP/ EL Study).
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 6, p. 766, doi. 10.1111/jdi.12626
- By:
- Publication type:
- Article
Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 3, p. 395, doi. 10.1111/jdi.12570
- By:
- Publication type:
- Article
Mechanism of lipid-lowering action of the dipeptidyl peptidase-4 inhibitor, anagliptin, in low-density lipoprotein receptor-deficient mice.
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 2, p. 155, doi. 10.1111/jdi.12593
- By:
- Publication type:
- Article
Human serum albumin: Possible cause of insulin autoimmune syndrome.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 6, p. 919, doi. 10.1111/jdi.12515
- By:
- Publication type:
- Article
Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 5, p. 674, doi. 10.1111/jdi.12494
- By:
- Publication type:
- Article
Long-term safety and efficacy of a novel once-weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52-week open-label, phase 3 study.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 5, p. 718, doi. 10.1111/jdi.12499
- By:
- Publication type:
- Article
Japanese study of tofogliflozin with type 2 diabetes mellitus patients in an observational study of the elderly (J- STEP/ EL): A 12-week interim analysis.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 5, p. 755, doi. 10.1111/jdi.12513
- By:
- Publication type:
- Article